neffy® (epinephrine nasal spray) – Expanded indication
March 5, 2025 - ARS Pharmaceuticals announced the FDA approval of neffy (epinephrine nasal spray), for emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients aged 4 years and older who weigh 15 kg or greater.
Top